ReviewJournal of leukocyte biology2019

Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy.

Jianming Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.